Search results
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity - Vertex...
Benzinga· 8 hours agoLoading... Loading... Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals VRTX revealed ...
Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
GuruFocus.com via Yahoo Finance· 1 day agoOn May 20, 2024, Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX),...
Vertex Pharmaceuticals executive sells shares worth over $13k By Investing.com
Investing.com· 6 days agoThe sale took place on May 15, 2024, and involved 32 shares of Vertex Pharmaceuticals common stock...
Vertex CEO Kewalramani sells over $6.7 million in company stock By Investing.com
Investing.com· 1 day agoVertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX) CEO and President Reshma Kewalramani...
Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress
Zacks via Yahoo Finance· 2 days agoVertex Pharmaceuticals Incorporated VRTX has been benefiting from strong revenue growth, regulatory...
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' - Walmart (NYSE:WMT)
Benzinga· 15 hours agoWalmart Inc. reported a "really strong" quarter, with e-commerce sales surging 21%. Adjusted EPS was...
Stocks Step Back After Fed Minutes; Loar, Monday.com, VRTX In Focus
Investor's Business Daily· 1 day agoThe 10-year Treasury yield rallied a bit after the minutes from the May 1 Fed meeting were released....
Vertex Pharmaceuticals Inc TradeGate Stock Price Today | NASDAQ VRTX Live Ticker - Investing.com
Investing.com· 13 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
The 2030 Millionaire's Club: 3 Biotech Stocks to Buy Now
InvestorPlace· 16 hours agoWith the interest cuts coming up, it’s an ideal time to consider loading up on the top biotech...
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded by StockNews.com to “Strong-Buy”
ETF DAILY NEWS· 4 days agoStockNews.com upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a buy rating to a strong-buy rating in a report released on Sunday morning. William ...